Iridex (IRIX) Cash from Discontinued Operations (2011 - 2012)

Iridex's (IRIX) quarterly Cash from Discontinued Operations came in at 148000.0 in Q4 2012, down 16.38% year-on-year from 177000.0 in Q4 2011, and up 4.23% quarter-over-quarter from 142000.0 in Q3 2012.

Iridex (IRIX) Cash from Discontinued Operations (2011 - 2012) Analysis & Trends

Iridex's Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 148000.0 for Q4 2012.

  • On a quarterly basis, Cash from Discontinued Operations fell 16.38% year-over-year to 148000.0 in Q4 2012; TTM through Sep 2013 was 148000.0, a 79.56% decrease from a year earlier, with the FY2012 full-year figure at 695000.0, down 12.8% from the prior year.
  • Cash from Discontinued Operations grew to 148000.0 in Q4 2012 per IRIX's latest filing, from 142000.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 836000.0 in Q2 2011 and bottomed at 264000.0 in Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 183.52 Bn 176.22 Bn 6.27 Bn -
2 Stryker 128.83 Bn 125.95 Bn 3.81 Bn -
3 Medtronic 108.61 Bn 99.39 Bn 6.41 Bn -
4 Boston Scientific 68.35 Bn 66.90 Bn 3.61 Bn -
5 Edwards Lifesciences 48.53 Bn 44.86 Bn 1.29 Bn -
6 Dexcom 28.42 Bn 27.30 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.34 Bn 26.06 Bn 1.98 Bn -
8 Smith & Nephew 26.92 Bn 26.35 Bn - -
9 Koninklijke Philips 25.49 Bn 22.36 Bn 2.07 Bn -
10 Iridex 15.45 Mn 10.86 Mn 4.74 Mn -

Historic Data

Download Data
DateValue
Dec 29, 2012 148,000.00
Dec 29, 2012 148,000.00
Sep 29, 2012 142,000.00
Sep 29, 2012 142,000.00
Jun 30, 2012 604,000.00
Jun 30, 2012 604,000.00
Mar 31, 2012 -199,000.00
Mar 31, 2012 -199,000.00
Dec 31, 2011 177,000.00
Dec 31, 2011 177,000.00
Oct 1, 2011 48,000.00
Oct 1, 2011 48,000.00
Jul 2, 2011 -264,000.00
Jul 2, 2011 -264,000.00
Apr 2, 2011 836,000.00
Apr 2, 2011 836,000.00